Find and Pitch Jounalists, Get Your Story Covered

Tags: Tesla electric vehicles sales IBM qubit

	Profile	Recent Articles on Subject
1	1387865 PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	Seagen and Astellas announce results from EV-302 study - over 1 year ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Adjuvant Nivolumab Boosts Survival Outcomes in Muscle-Invasive Bladder Cancer - 6 days ago Add-On Cemiplimab Shows Promise as First-Line Treatment for Penile Cancer - 7 days ago Adding Radioligand to Enzalutamide Boosts OS in Metastatic CRPC - 9 days ago New Bispecific Shrinks NRG1 Fusion-Positive Lung, Pancreatic Tumors - 18 days ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 6 months ago Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer - 6 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 8 months ago PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - 11 months ago First-Line Nivolumab Plus Chemo Approved for Bladder Cancer - 12 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 12 months ago Cabozantinib Plus Atezolizumab Delays Progression in mCRPC - about 1 year ago FDA Approves Belzutifan for Advanced Renal Cell Carcinoma - about 1 year ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - over 1 year ago FDA OKs First Drug for Nasopharyngeal Carcinoma - over 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - over 1 year ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - over 1 year ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Illuccix therapy gets approval in the UK - 11 days ago Amgen’s lung cancer treatment gets conditional approval - about 2 months ago MHRA grants approval for bladder cancer drug erdafitinib - 4 months ago
4	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Grants Priory Review for Human Monoclonal Antibody Drug to Treat Muscle-Invasive Bladder Cancer - 3 months ago Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation - 3 months ago Utidelone Injectable Granted FDA Orphan Drug Designation for Breast Cancer Brain Metastasis - 11 months ago Novel Chemotherapy Method Could Decrease Lung Cancer Tumor Size - 12 months ago Phase 3 EVOKE-01 Study in Metastatic NSCLC Falls Short of Primary Endpoint - about 1 year ago FDA Approves Pembrolizumab Plus Chemotherapy to Treat Metastatic HER2-Negative Gastric, Gastroesophageal Junction Adenocarcinoma - over 1 year ago FDA Approves PD-L1 IHC 22C3 to Identify Gastric or Gastroesophageal Junction Adenocarcinoma - over 1 year ago
5	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Sequencing in Advanced Urothelial Carcinoma - 4 months ago TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 8 months ago Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC - about 1 year ago Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T - about 1 year ago 'Exploding' Field of Antibody-Drug Conjugates Makes Inroads in Ovarian Cancer - about 1 year ago Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer - about 1 year ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - about 1 year ago Anti-TIGIT Drug Fails to Lift Response Rates in Cervical Cancer Trial - over 1 year ago The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer - over 1 year ago
6	Kristen Monaco MedPage Today	Complement Inhibitor Shows Promise for Rare Kidney Disorder - 4 months ago
7	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Gilead Sciences Voluntarily Pulls Drug for Bladder Cancer After Trial Failure - 4 months ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma - 6 months ago FDA Grants Fast Track Designation to Potential Treatment for Clear Cell Renal Cell Carcinoma - 8 months ago FDA Grants Breakthrough Therapy Designation to NVL-520 for ROS1-Positive NSCLC - 12 months ago FDA Approves Enfortumab Vedotin, Pembrolizumab for Treatment of Urothelial Cancer - about 1 year ago FDA Approves Belzutifan for Treatment of Advanced Renal Cell Carcinoma - about 1 year ago FDA Approves Enzalutamide for Nonmetastatic Castration-Sensitive Prostate Cancer - over 1 year ago
9	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical - 9 months ago
10	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	FDA Approves Earlier Use of CAR-T Products for Myeloma - 11 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - about 1 year ago

Journalists covering Locally Advanced or Metastatic Urothelial Carcinoma,antibody drug conjugate,PD-1/L1 inhibitor ,urothelial carcinomas